Tyr255
Javascript is not enabled on this browser. This site will not work properly without Javascript.
PhosphoSitePlus Homepage PhosphoSitePlus® v6.8.2
Powered by Cell Signaling Technology
Home > Phosphorylation Site Page: > Tyr255  -  CK2A1 (rat)

Site Information
VLGTEDLyDYIDKYN   SwissProt Entrez-Gene
Blast this site against: NCBI  SwissProt  PDB 
Site Group ID: 450324

In vivo Characterization
Methods used to characterize site in vivo:
phospho-antibody ( 1 , 2 ) , western blotting ( 1 , 2 )
Disease tissue studied:
Status epilepticus ( 2 )
Relevant cell line - cell type - tissue:
'brain, hippocampus' ( 2 ) , astrocyte ( 1 )

Upstream Regulation
Treatments:
3CAI ( 1 ) , GYKI 52466 ( 2 ) , NAC ( 1 ) , perampanel ( 2 )

Downstream Regulation
Effects of modification on biological processes:
autophagy, induced ( 1 )

Disease / Diagnostics Relevance
Relevant diseases:
Status epilepticus ( 1 , 2 )

References 

1

Kim JE, et al. (2023) Distinct Roles of CK2- and AKT-Mediated NF-κB Phosphorylations in Clasmatodendrosis (Autophagic Astroglial Death) within the Hippocampus of Chronic Epilepsy Rats. Antioxidants (Basel) 12
37237886   Curated Info

2

Kim JE, Lee DS, Park H, Kang TC (2020) Src/CK2/PTEN-Mediated GluN2B and CREB Dephosphorylations Regulate the Responsiveness to AMPA Receptor Antagonists in Chronic Epilepsy Rats. Int J Mol Sci
33348808   Curated Info

PhosphoSitePlus® is a registered trademark of Cell Signaling Technology.
Use of PSP data is subject to a formal license agreement. Learn more

©2003-2025 Cell Signaling Technology, Inc.